Previous study showed that SIRT6 might act as antioncogenesis factor by inhibiting HIF-1α, an angiogenesis-promoting molecule, in lung cancer [62], and by inhibiting c-Myc gene and ribosome biosynthesis [63]. This evidence concerns the gene MYC and lung carcinoma.